HopeStage
Back to all studies
WithdrawnNCT02333149

Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population

Placebo comparisonAges 6–17Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 17 years.

Listed locations
EdmontonSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2019
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University of Alberta
Sponsor type
University
Study type
Drug
Intervention type
Dietary supplement, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
From 6 Years to 17 Years
Official registry ID
NCT02333149
Official title
Show the full official title

Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population

Recruitment & locations

Withdrawn

Edmonton

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Alberta, a university.

Does this study involve medication?

Yes. The study involves medication, including Placebo.

Who can participate?

Listed age limits: 6 years to 17 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies